Inventor
SOUERS ANDREW J
US52 patents
⚠️ This page may combine multiple inventors who share the name “SOUERS ANDREW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
24 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9045475B2Jun 2, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC14 citations93
US9315488B2Apr 19, 2016
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC13 citations92
US9029404B2May 12, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations92
US8952157B2Feb 10, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC22 citations91
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9034875B2May 19, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations84
US8883784B2Nov 11, 2014
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9403822B2Aug 2, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC9 citations83
US10676485B2Jun 9, 2020
Macrocyclic MCL-1 inhibitors and methods of use
ABBVIE INC2 citations73
US10640563B2May 5, 2020
Anti-B7-H3 antibodies and antibody drug conjugates
ABBVIE INC3 citations69
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9227963B2Jan 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC2 citations62
US11964990B2Apr 23, 2024
1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors
ABBVIE INC1 citations59
US11759527B2Sep 19, 2023
Anti-EGFR antibody-drug conjugates
ABBVIE INC0 citations58
US9650358B2May 16, 2017
Pyridine CDK9 kinase inhibitors
ABBVIE INC1 citations52
US9359296B2Jun 7, 2016
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US9156856B2Oct 13, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
US9035047B2May 19, 2015
7-substituted indole Mcl-1 inhibitors
ABBVIE INC1 citations52
US8969375B2Mar 3, 2015
CDK9 kinase inhibitors
ABBVIE INC2 citations51
ABBOTT LAB
6 patentsUS8343967B2Jan 1, 2013
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBOTT LAB32 citations92
US6989392B2Jan 24, 2006
2-Aminoquinolines as melanin concentrating hormone receptor antagonists
ABBOTT LAB39 citations91
US7981888B2Jul 19, 2011
1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives
ABBOTT LAB8 citations84
US7071182B2Jul 4, 2006
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
ABBOTT LAB6 citations62
US6921821B2Jul 26, 2005
Antagonists of melanin concentrating hormone receptor
ABBOTT LAB7 citations60
US7049307B2May 23, 2006
Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
ABBOTT LAB1 citations51
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97
BAELL JONATHAN BAYLDON
3 patentsJUDD ANDREW S
2 patentsLIU GANG
2 patentsSOUERS ANDREW J
2 patentsDOHERTY GEORGE A
1 patentHEXAMER LAURA A
1 patentDING HONG
1 patentGENENTECH INC
1 patentKUNZER AARON R
1 patentTAO ZHI-FU
1 patentWANG XILU
1 patentSONG XIAOHONG
1 patentShowing the top 50 of 52 patents by PatentIndex Score.